Browse medicines
Some records contain detailed evidence; others currently contain only basic identity and regulatory information. Reviewed conclusions appear only when they are available for a specific use and group of people.
Medicine type
Approval status
AllApproved in the United States (FDA)Approved in the European Union (EMA)In Phase 3 testingIn Phase 2 testingUsed in a way not covered by an approval, or made by a compounding pharmacyDietary supplement; not FDA-approved as a medicineFDA accelerated approval (based on an earlier result expected to predict benefit; follow-up evidence may be required)Laboratory or animal-stage researchControlled substance; no approved US useWithdrawn from the market
Amount of information
Showing 1–2 of 2 records
Aducanumab-avwa (Aduhelm)
Antibody medicineWithdrawn from the marketDetailed recordUse listed on the medicine record
A monthly infusion for early Alzheimer's disease, approved on a brain-scan measurement rather than on symptoms
Efalizumab (Raptiva)
Antibody medicineWithdrawn from the marketDetailed recordUse listed on the medicine record
A weekly injection for severe plaque psoriasis